A major policy shift has arrived after 34 years. ACIP, the CDC’s immunization advisory panel, voted 8–3 to end the universal Hepatitis B birth-dose recommendation for infants born to Hep-B-negative mothers, moving instead to shared decision-making between parents and clinicians. Supporters say it gives families more choice, while dissenting members cautioned that changing long-standing guidance may carry risks.
Long-Awaited Vaccine Reversal Finally Arrives
